- What’s fueling optimism for dentistry’s future
- Palomar Health’s outpatient arm experiences data incident
- Bon Secours Mercy Health posts 2.6% operating margin in Q1
- A maternal health disparity puzzling researchers
- American Academy of Pediatric Dentistry installs new president, officers
- What it takes to get a job at Anthropic
- Bon Secours doubles Virginia urgent care footprint
- Ochsner Health adds GI physician
- How an independent ASC convinced Anthem and UnitedHealthcare to disrupt surgical pricing
- 10 systems seeking radiology leaders
- Highmark posts $216M operating income in Q1
- Phase 1 Equity adds multilocation practice in Texas
- Arkansas system cuts 86 jobs, including management roles
- HCA Texas hospital taps COO
- 4 key stats on the oral surgeon workforce
- FIU, Baptist Health break ground on outpatient academic medical center
- North Carolina system taps president for 2 hospitals
- Privia Health inks deal with another independent practice
- Dr. Emile Rossouw appointed president of the American Board of Orthodontics
- Meet the physician named head of Amazon Health Services
- Clinic owner sentenced for $52M fraud scheme
- Acadia in the headlines: 6 things to know
- 26 behavioral health executive moves to know
- Duke Health moves forward with GI center after years-long delay
- 6 trends reshaping DSO activity
- Former Florida dental practice employee accused of destroying documents
- The 5 biggest ASC price tags in 2026
- Federal IDR fee drops from $115 to $15: 6 things ASC and anesthesia leaders should know
- Specialty dentist pay by state, adjusted for cost of living
- Is value-based care now code for cost-cutting?
- AstraZeneca gains 2nd bladder cancer nod in key expansion for Imfinzi
- Behavioral health hospital operator to pay $32M in Medicare fraud settlement
- Bangladesh Measles Surge Kills 500+ Children; Vaccine Delays Blamed
- Care navigation startup Garner Health banks $100M series E at $2.74B valuation
- HCA bolsters workforce pipeline with healthcare professional college acquisition
- South Carolina enacts bill requiring in-person exams for orthodontic treatment
- Plant-Based Diet May Cut Obesity Risk For Women In Menopause
- Qualitas Dental Partners increases credit facilities to fuel acquisitions
- Pharma leaders meet with PM Takaichi in push for Japan to retain R&D edge
- Penn Medicine, K Health partner to deploy AI clinical agents
- CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo
- CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo
- CMS finalizes changes to No Surprises Act dispute resolution process
- Smartwatch App Accurately Detects Major Epileptic Seizures
- Racial Gap Exists For Asthma Inhaler Use
- New Colon Cancer Screening Guidelines Add Blood And At-Home Tests
- CVS expands partnership with Salesforce for greater call center personalization
- Nurse Convicted In Patient's Death Turns Fatal Drug Error Into Cautionary Tale
- Wearable Ultrasound Patch Monitors High-Risk Pregnancies In Real Time
- Listen to the Latest ‘KFF Health News Minute’
- In a Vaccine-Skeptical California County, a Potential Playbook To Contain Measles
- Teladoc Health inks partnership with Walmart to expand virtual care services
- PharmaEssentia taps Incyte alum Eric Vogel as it eyes Besremi expansion
- Kaléo speaks up on allergy awareness to amplify patient stories
- Privacy and PetShops: Remarks at the Regulatory PETshop Series: Cryptographic Technologies and Financial Services Regulation
- NYC Health + Hospitals adds 2nd behavioral health housing site
- Mindfulness isn’t a perk anymore — it’s a workforce strategy
- ‘Standardize what protects the patient’: The balancing act in behavioral healthcare operations
- With Elahere building steam, AbbVie nets FDA nod for another ImmunoGen cancer asset
- Nebraska behavioral health workforce grew 49% since 2010: 4 notes
- Hospitals again ask FTC, DOJ for exemption from expanded premerger notification filings
- Coalition for Health AI unveils governance playbooks for responsible AI adoption
- 10 behavioral healthcare M&A deals in 2026
- Maryland psychiatric hospitals strained at 95% capacity: 5 things to know
- Amazon taps Roy Schoenberg to lead healthcare business as Neil Lindsay plans to step down
- Viridian, awaiting FDA decision, taps WuXi Bio in eye drug supply deal
- U.S. To Keep Ebola-Exposed Citizens In Kenya Under New Policy
- FDA clears 1st neuromodulation device for PTSD
- CAT on a Hot Tin Roof
- GLP-1 Meds May Help Slow the Spread of Certain Obesity-Related Cancers
- GoodRx launches subscription program for low-cost generic medications, telehealth services
- George Washington University locks deal to hand off debt-ridden physician practice to UHS
- Humana invests $83M in new Florida pharmacy distribution center
- As J&J separates from its orthopedics business, it's laying off 56 employees in New Jersey
- ASCO preview: With expectations jacked up, Akeso's ivonescimab to face scrutiny in high-stakes plenary
- An insider’s look at LillyDirect
- GLP-1 manufacturer CordenPharma strikes deal for peptide CDMO, lining up new production sites in US and China
- Weight-Loss Program Helps Women Battling Breast Cancer
- Younger U.S. Women of Color Face Rising Breast Cancer Deaths
- High Fitness Doesn’t Raise A-fib Risk In Young Men, Study Finds
- Cheaper, Alternative Health Plans Are Having A Moment, But Critics Urge Caution
- Ultrafine Wildfire Smoke Particles May Pose Serious Health Risks
- Readers Address Drugged Driving, Suicide Prevention, Worker Shortages
- Montana Hurries To Adopt Trump’s Medicaid Work Rules Amid Budget Woes
- Nurse Convicted in Patient’s Death Turns Fatal Drug Error Into a Cautionary Tale
- Amid policy and pricing headwinds, US healthcare and life sci faces 'vast field of opportunity': survey
- Amid policy and pricing headwinds, US healthcare and life sci faces 'vast field of opportunity': survey
- Biogen investigated by Italian regulator over multiple sclerosis ‘market abuse’ claims
- FDA delays ruling on AstraZeneca’s breast cancer drug after negative adcomm vote
- Eli Lilly wins argument over Noom’s GLP-1 dosing claims
- Remarks at the Stanford Rock Center for Corporate Governance
- Smart ring maker Oura files confidentially for IPO as consumer demand propels revenue growth
- Outlook moves toward potential US nod for thrice-snubbed eye drug with FDA appeal win
- JD Power: Cost pressures worsen member experience with commercial plans
- Trinity Health credits pay rates, cost management for its steady 1% operating margin
- Trump Admin Bars Key U.S. Researchers From Global Virus Response Talk
- Listen to the Latest ‘KFF Health News Minute’
- CVS sues to challenge Tennessee's new PBM law
- As calls for COINS Act expansion grow, will new rules sweep up China biotech licensing?
- Radiopharmaceutical outfit Lantheus mulls potential $7B takeover by Curium: Bloomberg
- Everyone Has A Family Doc, But Can You Get An Appointment?
- Many U.S. College Students With Psychosis Are Not Receiving Treatment
- Antibiotics Won't Help Ease Asthma-Linked Wheezing in Kids
- Yoga Eases Insomnia And Anxiety In Cancer Survivors, Study Finds
- SK bioscience links up with Colombia to enable local production of varicella vaccine
- After prior FDA manufacturing snub, Gilead's hepatitis D med Hepcludex nabs US nod
- Dust Yields Clues to Viral Outbreaks, Study Finds
- 3 Medical Routines That Older People May Not Need
- Cheaper, Alternative Health Plans Are Having a Moment, but Critics Urge Caution
- Acadia boosts ‘More To Parkinson's’ campaign with Ryan Reynolds, Parkinson’s voices
- Niowave kicks off construction of $75M radiopharmaceutical isotope plant in Michigan
- Wheel, b.well partner to build turnkey infrastructure behind AI-native virtual care
- Journalists Distill News on Ebola, Licensing Midwives, and California’s Budget
- Trump Bought Stock in Eli Lilly as His Policies Gave the Drugmaker a Big Boost, Documents Show
- Acting NIAID Chief Steps Down Amid Ebola, Hantavirus Concerns
- Sunscreen Confusion Puts More Americans At Risk For Melanoma
- ACAP warns final ACA rule adds further uncertainty to a market in flux
- Swoop acquires prescription fulfillment platform Nimble to support independent pharmacies
- 1 In 10 U.S. Surgeons Quit Practice, Study Warns Of Shortage
- Video Game Can Detect Depression In Minutes, Study Says
- Quitting Smoking Might Lower Your Dementia Risk
- Severe Asthma Often Comes With Other Serious Health Problems
- Efforts To Understand The Nation's Drugged Driving Problem Stall Under Trump
- 3 Medical Routines That Older People May Not Need
- RFK Jr. Fires Two Leaders Of Major U.S. Health Task Force
- Common Food Preservatives Linked to Major Heart Problems
- Migraine With Aura Linked To Middle-Age Stroke Risk
- Nicotine Vapes Triple Smokers' Odds Of Quitting Tobacco
- Fatty Liver Disease Increases Heart Attack Risk, Study Says
- Religious Anti-Abortion Center Finds Opportunity In Town Without OB-GYNs
- CPAP Insurance Rules Too Stringent, Deny Device Coverage To Sleep Apnea Patients Who Would Benefit
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- The failure of the ‘usual suspects’ approach to life science recruitment
- The failure of the ‘usual suspects’ approach to life science recruitment
- Statement on Novel Exchange-Traded Funds (ETFs)
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
- Rollback of PFAS Drinking Water Standards Raises Safety Fears
- Designing an agentic, future‑ready tech roadmap for emerging pharma
- The Boston Children’s Experience: Hidden ICU Risk and AI-Driven De-escalation
- The Boston Children’s Experience: Hidden ICU Risk and AI-Driven De-escalation
- How specialty practices can get more out of technology investments
- Artivion Completes Endospan Acquisition, Expands Aortic Arch Portfolio With FDA-Approved NEXUS System
- Artivion Completes Endospan Acquisition, Expands Aortic Arch Portfolio With FDA-Approved NEXUS System
- Your Handwriting Could Be a Window Into Your Aging Brain
- Real-World Evidence in the AI Era: What You Can Unlock Depends on What You Build On
- How Do Caffeine, Alcohol, Weed, Nicotine Affect MS Symptoms?
- Once-A-Day Pill Effective In Treating Sleep Apnea Without CPAP, Clinical Trial Says
- Teens Turning To Creatine, Not Steroids, For 'Looksmaxxing'
Clearly the ideology dies hard with this administration, but today's bulletin leaves many questions unanswered.
ACIP's actual recommendations are just four weeks old.
- That the CDC promote six risks and uncertainties;
- that patients should be informed of the risks of COVID-19 and its vaccination before receiving the shot;
- and that coronavirus vaccinations for all people should be based on “individual-based decision making.”
None of them are mentioned here.
Does this make DIFS noncompliant? Does it open Michigan to federal penalties or legal challenges?
What exactly are the "barriers" removed? Do they continue to block other medications from patient use and coverage? If the barriers aren't necessary for the COVID vaccine(s), why are they necessary for other care and treatment?
Will the state be compliant with this bulletin, or with ACIP, in its Medicaid program?
Hot links available in the DIFS presser.
DIFS Issues Bulletin to Ensure Michiganders Continue to Have Insurance Coverage for No-Cost COVID-19 Vaccines
Media Contact: DIFS-press@michigan.gov
Consumer Hotline: 877-999-6442, Michigan.gov/DIFScomplaintsFOR IMMEDIATE RELEASE: October 16, 2025
(LANSING, MICH) In response to Gov. Gretchen Whitmer’s Executive Directive, the Michigan Department of Insurance and Financial Services (DIFS) has issued a bulletin to ensure Michiganders continue to have health insurance coverage for no-cost COVID-19 vaccines. The bulletin reminds health insurers that plans in the individual and small group markets are required to continue to cover COVID-19 vaccines at no cost to consumers.
“Michiganders deserve access and coverage for COVID-19 vaccines, which is why I directed state departments to remove unnecessary barriers to ensure the COVID-19 vaccine is available to for Michiganders,” said Governor Whitmer. “According to medical experts, vaccines remain the safest and most effective way to stay healthy during this upcoming cold and flu season. I’m committed to providing Michiganders with the best options for staying safe and healthy.”
"Governor Whitmer’s Executive Directive is clear: we must ensure that vaccines remain available to Michiganders who want them so they can protect themselves and their loved ones,” said Director Fox. “Many insurers have already committed to continuing this vital coverage for COVID-19 vaccines, and today’s bulletin is another way to clear barriers and protect consumers. DIFS is prepared to assist consumers with any questions or concerns about their health insurance. Our live call center is available Monday through Friday, from 8 a.m. to 5 p.m., at 877-999-6442.”
The bulletin advises insurers in both the individual and small group markets that they are required to provide no-cost coverage for immunizations if the federal Advisory Committee on Immunization Practices (ACIP) includes the immunization in its recommendations. The ACIP continues to recommend the COVID-19 vaccine.
Consumers with questions about health insurance coverage for vaccines should contact their insurance company. If they cannot get the information they need or have additional questions, they should contact DIFS for assistance from 8 a.m. to 5 p.m. Monday through Friday at 877-999-6442. More information about health insurance coverages can be found at Michigan.gov/HealthInsurance.
....
It's always easy to offer gifts paid for by others.
Wednesday's provider bulletin expands on state COVID-19 vaccine requirements, continuing to minimize federal policy changes.
Sent by MDHHS, while looping in all health-related Michigan departments.
COVID-19 Vaccine Recommendations for Michigan
Public Health Bulletin for Health Care Providers - October 2025
Dear colleagues,As health care providers, you are among our most trusted voices in encouraging vaccine uptake and protecting Michigan communities.
This fall, we want to reinforce that 2025-26 COVID-19 vaccines are available statewide, and that they are critical in preventing severe health outcomes and deaths from COVID-19 infections.
Gov. Gretchen Whitmer’s Executive Directive 2025-7 and the Chief Medical Executive’s (CME) Standing Recommendation 2025-01 on COVID-19 vaccination were issued to remove barriers to accessing COVID-19 vaccines and to help ensure that all who want to get a COVID-19 vaccine can receive one.
The Standing Recommendation states that any person over the age of 6 months without contraindication who has not received a dose of a U.S. Food and Drug Administration (FDA)-approved or -authorized 2025-2026 COVID-19 vaccine may be considered to have an underlying condition that puts them at high risk for severe outcomes from COVID-19 and is thus eligible to receive an age-appropriate dose without additional barriers.
Michigan Department of Health and Human Services (MDHHS) COVID-19 vaccine guidance aligns with leading national medical organizations, including the American Academy of Pediatrics, American College of Obstetricians and Gynecologists, American Academy of Family Physicians and the American College of Physicians. Key Michigan medical groups also support this guidance. For patient-facing materials and other resources, including a COVID-19 vaccine FAQ, visit Michigan.gov/COVIDFluRSV.
Together, we can prevent illness, save lives and protect the health of our state. Thank you for continued work and partnership.
Sincerely,
Natasha Bagdasarian, MD, MPH, FIDSA, FACP
Chief Medical Executive, State of MichiganSarah Lyon Callo, MS, PhD
Senior Deputy Director and State Epidemiologist, MDHHS Public Health AdministrationInsurance coverage
COVID-19 vaccines remain available at no cost to most Michigan residents. Under Executive Directive 2025-7, MDHHS and the Michigan Department of Insurance and Financial Services (DIFS) are working to ensure that coverage under state-regulated health plans — including Medicaid and commercial insurance — continue to provide coverage.At the national level, America’s Health Insurance Plans reaffirmed in September that member plans will cover all immunizations that were recommended by the Advisory Committee on Immunization Practices as of Sept. 1, including COVID-19 and influenza vaccines, at no cost-sharing for patients through the end of 2026. This commitment provides stability for providers and reassurance for patients who may otherwise be concerned with cost.
At the state level, if patients do experience coverage denials or unexpected copays, encourage them to contact their health insurer directly. DIFS is also prepared to assist consumers with questions or concerns about their health insurance. Their call center is available Monday through Friday from 8 a.m. to 5 p.m., at 877-999-6442.
Licensee support
Michigan has taken steps to ensure that providers and pharmacists have the authority and protection needed to administer COVID-19 vaccines under the standing recommendation.Michigan Department of Licensing and Regulatory Affairs (LARA) reminds licensed health professionals that Michigan law authorizes them to administer the COVID-19 vaccine to any individual — including those outside the FDA-approved categories — if that professional is doing so under the direction of a physician. This authority also applies to pharmacists who have a collaborative-practice agreement with a prescriber.
LARA also notes that the CME Standing Recommendation 2025-01 will be taken into consideration should LARA receive a complaint against a health professional regarding the administration of this vaccine.
Provider action steps
We encourage you to take these steps to increase vaccine uptake among your patients:Review CME Standing Recommendation 2025-01 and update internal protocols to reflect universal COVID-19 vaccine eligibility for all patients 6 months and older.
A patient’s statement that they have not yet received the 2025-26 COVID-19 vaccine is sufficient to determine eligibility.
Continue to counsel patients on the benefits and risks of vaccination.
Co-administer COVID-19 vaccines with other routine vaccines, including influenza and RSV vaccines where appropriate – to maximize uptake and reduce missed opportunities.
Provide staff education so that nurses, medical assistants and front-line personnel can confidently answer patient questions.
Monitor insurance coverage challenges and report recurring patterns of denial or copays to MDHHS or DIFS.
Consider becoming a Vaccines for Children (VFC) provider. The pediatric COVID-19 vaccine is available to order through VFC and MDHHS strongly encourages all enrolled providers to carry it.
Additionally, please join the Michigan State Medical Society on Tuesday, Nov. 4, from 12 to 12:45 p.m., to hear a vaccine update from Dr. Natasha Bagdasarian. Dr. Bagdasarian will cover the latest developments, recommendations and public health strategies surrounding key vaccines. Any health care provider in Michigan may register for this free event.2025-2026 COVID-19 Vaccine – Provider FAQ
Why was CME Standing Recommendation 2025-01 issued? CME Standing Recommendation 2025-01 was issued to provide clarity for both patients and providers, and to remove barriers to vaccine access. If an individual has not yet received the 2025-26 COVID-19 vaccine, they may consider themselves high risk when answering screening questions at their pharmacy, provider’s office or local health department. This approach ensures broad eligibility while allowing health care providers to follow MDHHS’ guidance and remain consistent with updated FDA label language.How should I document eligibility in my electronic health record (EHR) or on screening forms? It will depend on your specific EHR or screening and/or intake forms. To remain consistent, record that the patient has not received a 2025-26 COVID-19 vaccine and add a brief note that eligibility is determined under the CME Standing Recommendation 2025-01.
How should insurance coverage work? The COVID-19 vaccine is covered at no cost for most Michigan residents. Medicaid, Medicare and most commercial insurance plans cover the vaccine. Nationally, health insurers have reaffirmed that they are committed to ensuring no-cost coverage. If a patient is billed unexpectedly, instruct them to contact their plan. DIFS is also prepared to assist consumers with questions or concerns about their health insurance. Their call center is available Monday through Friday from 8 a.m. to 5 p.m., at 877-999-6442.
What liability protections are in place for providers administering COVID-19 vaccines under the standing recommendation? LARA has confirmed that the CME Standing Recommendation 2025-01 will be considered in oversight and complaint review. Providers acting within the scope of the recommendation and their license/scope of practice have regulatory support to vaccinate eligible patients.
What is the process for reporting vaccine administration in the Michigan Care Improvement Registry (MCIR)? As you do for all other routine vaccines, health care providers must report in MCIR all immunizations administered to every child born after Dec. 31, 1993, and under 20 years of age within 72 hours of administration and ideally within the same timeframe for all other adults. Confirm that your EHR interface is sending successfully.
How can I help reduce barriers to vaccine uptake in my practice? Offer COVID-19 vaccination at every eligible visit and co-administer with other routine vaccines, including with flu and RSV vaccines when appropriate. Use clear eligibility messaging and send out reminders to any under-vaccinated groups that you serve. Ensure that staff are prepared to answer common questions and track any recurring insurance coverage issues to share with MDHHS or DIFS.
Who can participate in shared clinical decision-making for vaccines? Primary care physicians, specialist physicians, physician assistants, nurse practitioners, registered nurses and pharmacists can practice shared clinical decision-making. These types of discussions on benefits and risks already occur in most clinical interactions, e.g. providing vaccine information sheets and asking if the patient or guardian has any questions.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















